Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New project – Infotagion Covid-19

30 Mar 2020 07:30

RNS Number : 0064I
Iconic Labs PLC
30 March 2020
 

 

30th March 2020

Iconic Labs Plc ("Iconic Labs" or the "Company")

New project - Infotagion Covid-19

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, is pleased to provide the following update.

Infotagion: Covid-19

The Company announces that, in partnership with Damian Collins MP, former Chair of the Digital, Culture, Media and Sport select committee, who also led the inquiries on disinformation and fake news, it has established 'Infotagion: Covid-19'. Infotagion: Covid-19 is an independent online and social media expert fact checking service to combat disinformation about the Covid-19 pandemic and its related economic and social effects, that are spreading through social media.

This service is being provided on a not for profit basis and is supported by people who believe that in the age of information contagion we need to help the truth fight back against the virus. The aim of Infotagion is to combat fake news which can cause misinformation, and panic and potentially cause governments and health services to divert resources away from where they are needed most.

Backers of Infotagion so far include a cross party group of current and former parliamentarians, members of the House of Lords and a range of campaigners, academics and celebrities from across the world.

The service is completely free to access and its core message is, "If you see something that doesn't look right, check it on Infotagion or share it with us and we'll verify the facts from trusted sources of information."

The core of the service is a website (www.infotagion.com), designed by Lovegunn, an award-winning design agency,  on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, including academic experts in identifying disinformation, and using the latest public health information provided by trust sources including from the UK parliament, governments and the WHO. The website then gives "traffic light answers" as to whether the information is correct, and provides links to trusted information sources, such as WHO or government websites, and, in some cases, a short explanation.

The site should therefore provide an interactive, trusted source of information and verification within the social media and wider communities. The Company will then use its extensive contacts within both the media and social media industry and among the influencer community to promote this source of accurate information for the benefit of all.

Liam Harrington, Chief Business Officer of Iconic Labs said: "Social media is proving to be a very powerful and important asset to our communities in the current crisis. In particular it provides one of the most effective means by which people can maintain essential interaction with others, and preserve communities, during this period of social distancing and isolation.

"However, there is another side in that social medial is one of the primary forums in which disinformation, whether circulated innocently or deliberately, is prevalent. We are therefore very pleased to be able to play a role in helping to counter disinformation about the current Covid-19 pandemic by bringing our expertise and skills to bear on the problem."

 

John Quinlan, Chief Executive Officer of Iconic Labs said: "At a time where people are being able to volunteer to help where they can, we are delighted to be able to use our skills and contacts where they will be most useful. For Infotagion to have received such widespread support and backing so quickly is really encouraging and hopefully it will be able to help the authorities and the public at this challenging time. "

 

Damian Collins MP, said: "The spread of disinformation through social media is particularly dangerous, and so I am very pleased that David Sefton introduced me to John, Liam, Sam and the whole Iconic Labs team, whose background experience at UNILAD is exceptional, and who I believe can play a key role with the social media world and elsewhere online in helping to dispel disinformation and disseminate correct information."

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Iconic Labs Plc (LSE:ICON), is a multi-divisional new media and technology business set up by Liam Harrington, John Quinlan and Sam Asante. The initial focus is to expand the content platform, suite of digital brands, and technology products both organically and through acquisitions in addition to consultancy and agency services.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEASDEDSPEEEA
Date   Source Headline
15th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20232:05 pmRNSSecond Price Monitoring Extn
15th Mar 20232:00 pmRNSPrice Monitoring Extension
15th Mar 20239:05 amRNSSecond Price Monitoring Extn
15th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20232:05 pmRNSSecond Price Monitoring Extn
28th Feb 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:57 amRNSChange of Registered Office
28th Feb 20237:56 amRNSTotal Voting Rights
24th Feb 20234:35 pmRNSPrice Monitoring Extension
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
21st Feb 20234:40 pmRNSSecond Price Monitoring Extn
21st Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20232:05 pmRNSSecond Price Monitoring Extn
21st Feb 20232:00 pmRNSPrice Monitoring Extension
20th Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:49 amRNSDirector Appointment
16th Feb 20239:05 amRNSSecond Price Monitoring Extn
16th Feb 20239:00 amRNSPrice Monitoring Extension
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR-1 notification
15th Feb 20233:00 pmRNSTR1 notification
15th Feb 20233:00 pmRNSTR1 notification
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSSubscription of Convertible Notes
9th Feb 20232:00 pmRNSPrice Monitoring Extension
9th Feb 20231:04 pmRNSConversion of Securities
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20232:05 pmRNSSecond Price Monitoring Extn
8th Feb 20232:00 pmRNSPrice Monitoring Extension
6th Feb 20237:18 amRNSConversion of Notes
2nd Feb 20237:55 amRNSRestructuring Update
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20238:52 amRNSTotal Voting Rights
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.